Protective Effects of Cirsilineol against Lipopolysaccharide-Induced Inflammation; Insights into HO-1, COX-2, and iNOS Modulation

Pharmacology, Toxicology and Pharmaceutical Science

• Inducible Nitric Oxide Synthase 100%
• Cyclooxygenase 2 100%
• Heme Oxygenase 1 100%
• Lipopolysaccharide-Induced Inflammation 100%
• Lipopolysaccharide 57%
• Inflammation 28%
• Antioxidant 28%
• Tumor Necrosis Factor 28%
• Interleukin 1 28%
• STAT1 Protein 28%
• Malignant Neoplasm 14%
• Natural Product 14%
• Antiinfective Agent 14%
• Anti-Inflammatory Drug 14%
• Mouse 14%
• Luciferase 14%
• Fibrinogen 14%
• Artemisia 14%

Biochemistry, Genetics and Molecular Biology

• Lipopolysaccharide 100%
• Nitric Oxide Synthase 100%
• Heme Oxygenase 100%
• Cyclooxygenase 100%
• Tumor Necrosis Factors 28%
• Interleukin-1 28%
• Transcription Factor Nrf2 28%
• STAT1 28%
• Cancer Cell 14%
• Liquid 14%
• Mouse 14%
• RNA Interference 14%
• Animal Model 14%
• Anticancer 14%
• Binding Affinity 14%
• Luciferase 14%
• Artemisia 14%
• Antibacterial Activity 14%

Immunology and Microbiology

• Heme 100%
• Tumor Necrosis Factor Alpha 50%
• Interleukin 1 50%
• Umbilical Vein Endothelial Cell 50%
• Transcription Factor Nrf2 50%
• STAT1 50%
• Inflammation Response 25%
• Cancer Cell 25%
• Mouse 25%
• Binding Affinity 25%
• Antibacterial Activity 25%
• RNA Interference 25%
• Artemisia 25%
• Bronchoalveolar Lavage Fluid 25%